BETRF (BetterLife Pharma) ROE % Adjusted to Book Value: 0.00% (As of Apr. 2026)


BETRF BetterLife Pharma Inc BETRF
28 GF Score
Price $0.10
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma ROE % Adjusted to Book Value?

BetterLife Pharma BETRF -10.07% 28 ROE % Adjusted to Book Value is 0.00% as of Apr. 2026. GuruFocus rates BETRF with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

BetterLife Pharma's ROE % for the quarter that ended in Apr. 2026 was 0.00%. BetterLife Pharma's PB Ratio for the quarter that ended in Apr. 2026 was N/A. BetterLife Pharma's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2026 was N/A.

BetterLife Pharma ROE % Adjusted to Book Value Related Terms

BetterLife Pharma ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma ROE % Adjusted to Book Value Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BetterLife Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Jan26 Apr26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BETRF vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, BetterLife Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BetterLife Pharma ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's ROE % Adjusted to Book Value falls into.


BETRF
28GF Score
BetterLife Pharma Inc BETRF
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma ROE % Adjusted to Book Value Calculation

BetterLife Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Jan. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

BetterLife Pharma's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
BetterLife Pharma (BETRF) has a ROE % Adjusted to Book Value of 0.00% as of Apr. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on BetterLife Pharma and its competitors.
Is BetterLife Pharma's ROE % Adjusted to Book Value too high?
BetterLife Pharma's current ROE % Adjusted to Book Value is 0.00%. Overall, BetterLife Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's ROE % Adjusted to Book Value compare to VRTX and REGN?
BetterLife Pharma's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. BetterLife Pharma's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current ROE % Adjusted to Book Value is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges NPAU:GermanyBETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
28GF Score

Get the complete analysis for BETRF

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price